Animal experiments have demonstrated that microbial metabolites, specifically SCFAs, can regulate CD8+ T cell responses and enhance the metabolic adaptability of CAR‐T cells, thereby improving their cytotoxic effects against tumor cells [141]. This evidence concerns the gene CD8A and neoplasm.